Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
What will members gain?

Download Now: New Slide Deck Programme

Slide decks focusing on key results and expert analysis from FOURIER and ODYSSEY OUTCOMES – two landmark trials in PCSK9 inhibition.

Find out more »

Most viewed

Hot Topics

PCSK9 inhibitors work – but access is the problem
Prof Chris Packard (University of Glasgow, UK)
The take home message from this US study: A high absolute risk reduction (in high-risk patients with high LDL-C) is paramount to the cost effectiveness of PCSK9 inhibitors.

Read the Report

Recent Hot Topics:

Prof Børge Nordestgaard: Lipoprotein(a): a therapeutic target in guidelines?
Listen to the presentation
Prof Raul Santos: Coronary artery calcium in familial hypercholesterolaemia Read the Report

From the Editors

Targeting PCSK9 inhibitors to the right patient

Professor Stephen J Nicholls (Monash University, Melbourne, Australia)

FOURIER and ODYSSEY OUTCOMES clearly demonstrate that PCSK9 inhibitors reduce cardiovascular events. The question is: How do we target PCSK9 inhibition to very high risk patients most likely to benefit?

Read the report
Watch the video

Professor Derick Raal: LDL cholesterol goals in patients with diabetes – How low?
Read the report

ACC 2017

Meet our Editorial Board

View all our Editorial Board Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research Dr Michel FarnierClinician based at Point Medical, Dijon, France Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology